GLP-1 drugs are increasingly marketed as lifestyle products rather than medical treatments

Pioneer pharmaceutical company Novo Nordisk is increasingly marketing its blockbuster GLP-1 drug, Wegovy, as a lifestyle and weight loss product rather than a medical treatment. In global advertisements with slogans like "Live lighter" and "Summer Glow Up," the company has shifted away from terms like "weight management" and now refers to users as "customers" instead of patients.